Most active investors · All time
Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
Browse by month
Details
Details
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Prosper AI $30M Series ARadical Numerics $50M SeedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
HistoSonics Undisclosed StrategicTurquoise Health $40M Series CDetails
New companies 2 · Follow-on 0
Stages: Series A 2
Syntax Bio $14.4M Series A+Latus Bio, Inc. $97M Series ADetails
Details
Details
New companies 2 · Follow-on 0
Stages: Series A 2
Dioseve $7M Series A+Kanvas Biosciences $48M Series ADetails
Details
New companies 2 · Follow-on 0
Stages: Series A 2
Turnout Technologies $35M Series ATake2 $14M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
FesariusTherapeutics $20M Series AJuvena Therapeutics $33.5M Series BDetails
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Nanordica Medical €1.6M SeedFreestyle $10M Series ADetails
New companies 2 · Follow-on 0
Stages: Series C+ 2
GT Medical Technologies $100M Series ENeurent Medical €62.5M Series CDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
The Portal $5M UndisclosedAmpa Undisclosed UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Stepful $55M Series CVista AI $29.5M Series BDetails
New companies 2 · Follow-on 0
Stages: Series B 2
City Therapeutics $99.5M Series BVitestro $70M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
CereVasc $85M Series CResolve M Therapeutics Undisclosed UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
CereVasc $85M Series CPulnovo Medical $100M StrategicDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series C+ 1
Semble £30M Series CIntron $1.6M Pre-seedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
IMU Biosciences $53M Series APontiro £357K SeedDetails
New companies 1 · Follow-on 1
Stages: Series C+ 2
Garner Health $100M Series EGarner Health $118M Series DDetails
Details
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Lucis $20M Series APatronus €11M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
The Path $14.3M SeedJoyful Health $17M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
The Path $14.3M SeedGilgamesh Pharma $60M Series ADetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Cagent Vascular $41M Series DNervonik $52.5M Series BDetails
New companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Full-Life Technologies $150M Series D+DebtButterfly Medical $21M Series CDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Full-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPO“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.